IX 709 (Dexmethylphenidate Hydrochloride Extended-Release 25 mg)
Pill with imprint IX 709 is Beige, Capsule-shape and has been identified as Dexmethylphenidate Hydrochloride Extended-Release 25 mg. It is supplied by Impax Pharmaceuticals.
Dexmethylphenidate is used in the treatment of adhd; auditory processing disorder and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dexmethylphenidate 25 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for IX 709
Dexmethylphenidate Hydrochloride Extended-Release
- Imprint:
- IX 709
- Strength:
- 25 mg
- Color:
- Beige
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Labeler / Supplier:
- Impax Pharmaceuticals
- National Drug Code (NDC):
- 00115-1709
More about dexmethylphenidate
- Dexmethylphenidate Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 150 Reviews
- Drug class: CNS stimulants
Consumer resources
- Dexmethylphenidate
- Dexmethylphenidate Tablets
- Dexmethylphenidate Extended-Release Capsules
- Dexmethylphenidate (Advanced Reading)
Other brands: Focalin, Focalin XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
